The Campbell's Company has entered a period of compressed valuations and cautious sentiment as elevated input costs and a challenged snacks portfolio overshadow steady demand for its meals and beverages business. Shares have traded in a range of roughly $21 to $24 over the past month, with the stock pulling back following its late fiscal 2026 earnings release. The company remains a widely followed packaged-foods name, but investors are now weighing the near-term earnings reset against the potential for margin recovery through pricing, productivity, and cost discipline. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Headquartered in Camden, New Jersey, and founded in 1869, The Campbell's Company is a North American packaged-food leader organized into two reporting segments: Meals & Beverages and Snacks. Its portfolio includes iconic brands such as Campbell's, Goldfish, Pepperidge Farm, Cape Cod, Chunky, Kettle Brand, Lance, Late July, Pace, Pacific Foods, Prego, Snyder's of Hanover, Swanson, V8, and the premium Italian sauce brand Rao's. The company completed the acquisition of Sovos Brands in 2024, bringing Rao's into the fold, and acquired a stake in La Regina in 2026 to support further category expansion. Investors follow CPB for its durable brand franchises, strong cash generation, and dividend history, while monitoring its ability to navigate cost inflation and shifting consumer preferences in center-store and snack categories.
The most significant development in the past month was Campbell's fourth-quarter fiscal 2026 earnings release, which disappointed on multiple fronts. Adjusted earnings per share fell 37% year over year to $0.39, net sales declined 8% to about $2.14 billion, and organic sales decreased 1%. Adjusted gross margin contracted 190 basis points to 28.6%, reflecting cost inflation, tariffs, and other supply-chain costs that outweighed productivity gains.
The results showed a clear divergence between the company's two segments. Meals & Beverages delivered 3% organic sales growth, with Rao's consumption up 9.6% in the quarter. By contrast, Snacks organic sales fell 6%, and segment operating earnings dropped 34%, driven by weakness in the salty snacks portfolio even as core Goldfish consumption returned to growth.
In response, management announced a 36% reduction in the quarterly dividend to $0.25 per share, a move intended to accelerate debt reduction after net leverage reached 4.3 times. The company also launched an enterprise-wide savings program targeting $500 million in cost reductions by fiscal 2030, with more than $100 million expected in fiscal 2027 alone, alongside plant closures and a roughly 13% reduction in the salaried workforce. Campbell's also signaled targeted price increases across a majority of its portfolio to offset persistent inflation. The weak fiscal 2027 guidance, which projects net sales and organic sales declines of 2% to 4% and adjusted EPS of $1.65 to $1.80, contributed to the post-earnings selloff. From what I see, this combination of factors explains much of the recent price action in CPB.
Campbell's fiscal 2027 guidance frames a year of continued near-term pressure before improvement is expected to build. Management anticipates raw-material and packaging inflation of 5% to 6%, double-digit logistics inflation, and a low-single-digit benefit from net pricing. The company expects the fiscal first quarter to carry the heaviest margin pressure, with performance improving sequentially as productivity, savings, and pricing actions take effect.
Key factors to monitor include the pace of the Snacks turnaround, the durability of Rao's and Meals & Beverages momentum, the execution of the $500 million cost-savings program, and progress toward the company's longer-term leverage target of roughly three times. Consumers' response to price increases, competitive dynamics in salty snacks, and the trajectory of agricultural commodity and logistics costs will also influence results. The reset dividend and balance-sheet priorities signal management's focus on debt reduction, but the path to margin recovery depends on disciplined execution against a volatile cost environment. These factors will remain central to how investors assess CPB's valuation and earnings trajectory through fiscal 2027. I'm watching this closely as the cost environment evolves.
In my view, pairing traditional research with data-driven signals can add useful perspective when evaluating names like CPB. I often review Tickeron’s Trending AI Robots page for a curated look at AI-driven strategies across different risk profiles and time horizons. It helps surface approaches that complement my own fundamental work without replacing it.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Oscillator for CPB moved into overbought territory on September 04, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CPB advanced for three days, in of 283 cases, the price rose further within the following month. The odds of a continued upward trend are .
CPB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 192 cases where CPB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 59 cases where CPB's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on September 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CPB as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for CPB turned negative on August 27, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .
CPB moved below its 50-day moving average on September 03, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CPB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.656) is normal, around the industry mean (5.862). P/E Ratio (16.321) is within average values for comparable stocks, (35.572). Projected Growth (PEG Ratio) (0.711) is also within normal values, averaging (2.773). Dividend Yield (0.073) settles around the average of (0.058) among similar stocks. P/S Ratio (0.658) is also within normal values, averaging (4.978).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CPB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CPB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of convenience food products, such as soups and sauces, pasta, broths, vegetable-beverages, cookies and biscuits
Industry FoodMajorDiversified